ALLO vs PEG · rev $22.0K vs P/E 18, rev $10.29B
Allogene Therapeutics Inc (ALLO) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
ALLO currently screens at market cap $258.1M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the ALLO and PEG stock pages for the full models.
Not investment advice.